期刊文献+

颈交感神经切断对臂丛神经节神经肽Y含量及前肢痉挛影响的实验研究 被引量:1

Experimental study about contribution of sympathetic nerve amputation to neuropeptide Y content in brachial plexus and spasmodic muscles in foreleg
下载PDF
导出
摘要 目的探讨臂丛神经内神经肽Y含量与痉挛骨骼肌之间的关系。方法将16只右侧大脑皮层损伤模型Wis-tar大白鼠随机分成两组(各8只),实验组行颈上节交感神经切断术,对照组不予任何处理。于术后第20天对各动物相同切取相同部位左臂丛神经组织,用免疫组织化学方法检测其神经肽Y(NPY)百分率并做定量分析。同时观察左前肢术后神经症状和进行屈肘肌群痉挛评定。结果实验组大鼠左臂丛神经内NPY含量明显低于对照组,差异有统计学意义(P<0.05);大部分实验组动物患肢神经症状改善。结论交感神经切断术治疗大脑损伤性肌痉挛的机制可能与降低神经局部的NPY含量有关。 Objective To study the relationship between the neuropeptide Y content (NPY) in brachial plexus and spasmodic muscles. Methods 16 Wistar rat models that were injured on right cerebral cortex were diveded into two groups (8 rats in each group): the experiment group were operated superior cervical sympathectomy, while the control group were not treated. The same left braehial plexus tissue of each rats were removed through sympathectomy on 20th day; then the NPY percentage was examined and quantitative analysis was made through immunohistochemical method. Meanwhile, the nerve symptom was observed and the spasm of flexion elbow muscles on left foreleg was assessed after sympathectomy. Results The NPY content of left braehial plexus was significantly lower in experiment group than control group (P 〈 0.05). The nerve symptom of the affected limbs was improved in most of experiment group rats after sympathectomy. Conclusion The treatment mechanism of sympatheetomy for myospasm resulting from cerebrum injury may be related to the decrease of local content of NPY.
出处 《中国医药导报》 CAS 2012年第19期33-34,37,共3页 China Medical Herald
基金 福建省自然科学基金资助项目(项目编号:2012J01432) 福建省医学创新课题(课题编号:2011-CX-34) 福建省泉州市第一批技术研究与开发项目(项目编号:2009Z28)
关键词 交感神经 臂丛神经 神经肽Y 骨骼肌 Sympathetic nervous Brachial plexus NPY Muscle
  • 相关文献

参考文献4

二级参考文献30

共引文献84

同被引文献43

  • 1张锦明,田嘉禾,川玲,刘自来.心肌摄取^(131)I-MIBG的影响因素[J].中华核医学杂志,1997,17(2):91-93. 被引量:1
  • 2Parati G, Esler M. The human sympathetic nervous system: its relevance in hypertension and heart failure[J]. Eur Heart J, 2012, 33(9): 1058-1066.
  • 3Grassi G, Bertoli S, Seravalle G, et al. Sympathetic nervous sys- tem:role in hypertension and in chronic kidney disease[J]. Curr Opin Nephrol Hypertens, 2012,21 (1) : 46-51.
  • 4Symplicity HTN-1 investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months[J]. Hypertension, 2011,57 (5): 911-917.
  • 5Christensen NJ. Methods of studying sympathoadrenal activity in man[J]. Acta Med Stand,1988,223(6) :481-483.
  • 6Axelro J, Reisine TD. Stress hormones: their interaction and reg- ulation[J]. Science, 1984,224(4648) :452-459.
  • 7Grassi G, Seravalle G, Brambilla G, et al. The sympathetic nerv- ous system and new nonpharmacologic approaches to treating hy- pertension:a focus on renal denervation[J]. Can J Cardiol,2012,28(3):311-317.
  • 8Hausberg M, Kosch M, Harmdink P, et al. Sympathetic nerve activity in end-stage renal disease[J]. Circulation, 2002,106 (15) :1974-1979.
  • 9Kotanko P. Cause and consequences of sympathetic hyperactivity in chronic kidney disease[J]. Blood Purif,2006,24(1) :95-99.
  • 10Straub RH, Schaller T, Miller LE, et al. Neuropeptide Y co- transmission with norepinephrine in the sympathetic nerve-macro- phage interplay[J]. J Neurochem, 2000,75 (6) : 2464-2471.

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部